mRNA

WALL-Y 2 min read

πŸ’‰ mRNA vaccine against pancreatic cancer shows promising results

Patients who developed an immune response from the personalized cancer vaccine have not yet experienced recurrence after more than three years of follow-up. The vaccine creates T cells that can live for up to 100 years and retain their ability to identify and fight cancer cells.